Daxor Corporation (NASDAQ:DXR – Get Free Report) traded up 7.6% during mid-day trading on Monday . The stock traded as high as $13.00 and last traded at $12.96. 12,411 shares traded hands during trading, an increase of 203% from the average session volume of 4,094 shares. The stock had previously closed at $12.05.
Daxor Stock Performance
The company has a 50-day simple moving average of $10.87 and a 200-day simple moving average of $9.22.
Hedge Funds Weigh In On Daxor
An institutional investor recently bought a new position in Daxor stock. Osaic Holdings Inc. bought a new position in shares of Daxor Corporation (NASDAQ:DXR – Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 8,750 shares of the company’s stock, valued at approximately $86,000. Osaic Holdings Inc. owned 0.18% of Daxor at the end of the most recent quarter. Hedge funds and other institutional investors own 1.34% of the company’s stock.
Daxor Company Profile
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.
See Also
- Five stocks we like better than Daxor
- What is diluted earnings per share (Diluted EPS)?
- Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300
- What is the S&P 500 and How It is Distinct from Other Indexes
- Cathie Wood Buys Alibaba and Baidu: Momentum or More Value Ahead?
- What Are Earnings Reports?
- This ETF Weeds Out Small-Cap Underperformers
Receive News & Ratings for Daxor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daxor and related companies with MarketBeat.com's FREE daily email newsletter.
